The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery
Recruiting · NCT06543420 · Interventional (participants receive a specific treatment) · Lead sponsor: Peking University First Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study is a single center, single blind, prospective randomized controlled trial. Patients undergoing robot assisted laparoscopic radical prostatectomy for prostate cancer were randomly divided into 1:1:1 groups, using lateral reconstruction, posterior reconstruction, or no reconstruction. Patients were followed up regularly after surgery and clinical data were collected, including daily use of urine pads, ICIQ-SF score, 24-hour urine leakage, I-QoL score, etc., to evaluate the improvement effect of lateral reconstruction on urinary control and the difference in effect between lateral reconstruction and posterior reconstruction, thereby improving the quality of life of prostate cancer patients after surgery.
Who can take part
Inclusion criteria
- Diagnosed with prostate cancer and preoperative clinical stage of cT2\~T3aN0M0
- Complies with the indications for RARP surgery
Exclusion criteria
- History of urinary incontinence or urethral stricture
- Previous prostate related surgical treatment
- Contraindications for RARP surgery
- The patient or their family members refuse to participate
Where it is running
1 location listed.
- Peking University First Hospital - Beijing, Beijing Municipality, China